Delving into the Latest Updates on Suzhou Ju Microbial Technology Co., Ltd with Synapse

Overview

Tags

Infectious Diseases

Respiratory Diseases

Other Diseases

Prophylactic vaccine

Inactivated vaccine

Conjugated vaccine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Infectious Diseases	4

Top 5 Drug Type	Count

Prophylactic vaccine	3
Inactivated vaccine	1
Therapeutic vaccine	1
Conjugated vaccine	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

3

1

Phase 1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

20-valent Pneumococcal Conjugate Vaccine (Suzhou VAC)	Pneumococcal Infections More	Phase 1
JW002	Meningococcal Infections More	Preclinical
JW010	Whooping Cough More	Preclinical
JW007	Pneumococcal Infections More	Preclinical